Representing over 350 physicians and educational institutions throughout California

Innovatix cordially invites healthcare professionals
to participate in a jointly offered lunchtime CE teleconference

Date: February 15, 2012
Topic: Medicare and Medicaid Changes: An Update for Health Providers
Presenters:
Brad Kile, PhD
S. Leigh Davitian, JD
Dumbarton Group and Associates
Time: 11:00am – 12:00pm Pacific

RSVP by Friday, February 10, 2012. Any questions please contact Shannon at (888) 258-3273 ext. 369 or ssteen@innovatix.com

ICD-9 to ICD-10 Transitions
As 5010 compliance was effective January 1, 2012 and 5010 is only a stepping stone to implement ICD-10, it is recommended you start perusing the crosswalk of the new diagnosis code set which must be transitioned from ICD-9 to ICD-10 by Oct. 1, 2013.

Announcing the permanent J-code J9179 for Halaven® (eribulin mesylate) Injection.
New J-code, J0897 for Prolia® and for XGEVA®

Strategies You Need to Know when Negotiating with Payers

ICD-9 Crosswalk to ICD-10
Medicare now covers the Pathwork(r) Tissue of Origin Test
 

MOASC Contracting Network (MCN) and Cardinal Health Specialty Solutions collaborate with Payors to improve quality, costs, accessibility of cancer care.

The LunchTime Series Teleconference was held on Wednesday, January 25, 2012. The presentation was on the “Billing and Coding Changes for 2012” presented by Bobbi Buell, Principal, onPoint Oncology, LLC. In case you missed the presentation, you can listen to the recording by dialing 1-888-203-1112 and enter the pass code 70734569#.  If you would like a copy of the handouts, please send an email to neast@moasc.org

The next LunchTime Series Teleconference is scheduled for Wednesday, February 29, 2012 at 12:00pm-PST. The Topic will be “2012 Human Resource Update” presented by Beverly Bailey, President, Bailey Strategic Human Resources. RSVP to the MOASC office or via email at neast@moasc.org


MCN Physician Webinars with Dr. Bruce Feinberg. Dr. Feinberg is an oncologist as well as Vice President and Chief Medical Officer of P4 Healthcare. Development and Organization of the clinical oncology pathway program within the MCN will be addressed as well as the various components of the MCN.

The webinar dates and times are as follows. To register, click on the link below and upon completed registration, you will receive a confirmation along with participation instructions.

Thursday, February 2, 2012 at 5:30 pm Pacific http://registration.p4healthcare.com/Meeting
Registration/Physician/Meet-005615

Monday, February 6, 2012 at 5:30pm Pacific http://registration.p4healthcare.com/Meeting
Registration/Physician/Meet-005616

Tuesday, February 7, 2012 at 12:00pm Pacific http://registration.p4healthcare.com/Meeting
Registration/Physician/Meet-005617

Wednesday, February 8, 2012 at 5:30 pm Pacific  http://registration.p4healthcare.com/Meeting
Registration/Physician/Meet-005618

Thursday, February 9, 2012 at 12:30pm Pacific http://registration.p4healthcare.com/Meeting
Registration/Physician/Meet-005619

If you have any questions, please call the MOASC Office at
909-985-9061 ext. 1.

The industrialization of medicine is here, whether we like it or not. Government policy is directing physicians to be affiliated with hospitals, in ACO's or IPA type organizations. We encourage you to become a Participating MCN Physician.

For our shared vision to be successful, it is vital that we create and maintain a robust network of MCN Physicians.

We can take control of OUR OWN DESTINY and partner with fellow oncologists for continued access to the best oncology care in the world.
 
MOASC represents over 350 physicians and educational institutions throughout California as an advocate for the practicing oncologist and their patients. We regularly meet with the local Medicare Carrier Medical Director, as well as state and federal legislators advocating and lobbying for increased awareness of oncology. We take a proactive approach, addressing the needs of the practicing oncologist to be able to provide the quality of care that cancer patients not only require, but deserve. We work as your representatives to CMS officials, Congressional Representatives, Federal and State agencies and insurance carrier administration personnel.

"The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care."

MOASC enables medical oncologists, nurses and administrators to improve cancer care by:

•  Working with patient advocacy groups;
•  Assisting Californians in developing laws and regulations;
•  Working with national associations;
•  Working with employers, payors, and CMS to reimburse satisfactorily and appropriately for medical treatments;
•  Documenting benchmarks for oncology practices;
•  Promoting the continued education of physicians, their staff, patients and society;
•  Promoting clinical trial enrollment;
•  Increasing the membership of community and academic oncologists in the Medical Oncology Association of Southern California (MOASC).

 
Invite Your Members of Congress to Your Practice TODAY!!!
 

Thank you to the following sponsors for assisting MOASC in achieving their mission.

Platinum: MOASC MPN, Celgene, McKesson Specialty Health, Oncology Supply/ION
Diamond: Lilly Oncology, Novartis
Gold: Pfizer, Sanofi Oncology, Amgen, Vital Source/Cardinal Health
Silver: Millennium, The Takeda Oncology Company, Merck Oncology, Allos Therapeutics,
AstraZeneca, Bayer Healthcare Pharmaceuticals, Cephalon, Eisai,
Genentech/Roche, Genomic Health, Glaxo SmithKline, Innovatix,Janssen Biotech, Inc, ONYX Pharmaceuticals, Prometheus, Seattle Genetics, Veridex, MedicoRX Specialty Pharmacy,

Other Sponsors: Pathwork DX, Dendreon, Boehringer Ingelheim, Astellas Oncology, BMS Optimal MD Solutions, Caris Life Sciences, PLUS Diagnostics

 
OUR VISION
The early portion of the 21 st Century will be an era in which progress, in the science and biology of cancer, will result in an explosion of new technologies with which to prevent, diagnose, treat and cure cancer. While this process will be a boon to cancer patients and society, it will come with substantial costs in an environment where finances may be limited. Cancer patients need protection to allow access to and delivery of optimal cancer management, including providing or coordinating cancer screening and detection, cancer/genetic counseling, cancer education, cancer prevention, cancer treatment, cancer symptom management, and cancer rehabilitation.


© 2008 - 2010 Medical Oncology Association of Southern California
P.O. Box 161   •    Upland, CA 91785
Phone: (909) 985-9061   •    Fax: (909) 985-8581   •   email: moasc@moasc.org

Open Central 

mckesson
 
inland empire website design wow webs